Lineage Cell Therapeutics, Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $1.9M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $-3.2M |
| SG&A Expense | $-2.3M |
| Operating Income | $-3.5M |
| Operating Margin | -182.9% |
| Interest Expense | — |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-5.1M |
| Net Margin | -267.2% |
| EPS (Basic) | $-0.18 |
| EPS (Diluted) | $-0.18 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |